Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 7/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.39 |
| ▸ | CDC14B | O60729 | 1/20 | 0.37 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.37 |
| ▸ | TTR | P02766 | 4/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.37 |
| ▸ | CTRC | Q99895 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | GABRP | O00591 | 1/20 | 0.36 |
| ▸ | GABRD | O14764 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.36 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.36 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31597560 | 1.00 | AHR (0.47) | AHRCYP2A6ALOX5CDC14BCDC14A | |
| SCHEMBL24672286 | 0.97 | AHR (0.45) | AHRCYP2A6ALOX5CDC14BCDC14A | |
| SCHEMBL24672213 | 0.88 | AHR (0.42) | AHRCYP2A6ALOX5CDC14BCDC14A | |
| SCHEMBL31393393 | 0.88 | AHR (0.47) | AHRCYP2A6ALOX5CDC14BCDC14A | |
| SCHEMBL13935844 | 0.87 | AHR (0.42) | AHRCYP2A6ALOX5CDC14BCDC14A | |
| SCHEMBL24255989 | 0.86 | AHR (0.41) | AHRTTR | |
| SCHEMBL13935802 | 0.85 | ALOX5 (0.42) | ALOX5CDC14BCDC14ACYP1A1CYP1A2 | |
| SCHEMBL31432558 | 0.84 | AHR (0.42) | AHRALOX5TTRCYP1A1CYP1A2 | |
| SCHEMBL20962219 | 0.84 | AHR (0.50) | AHRCYP2A6ALOX5CDC14BCDC14A | |
| SCHEMBL31120342 | 0.84 | AHR (0.50) | AHRCYP2A6ALOX5CDC14BCDC14A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11812623-B2 | Hetero-cyclic compound and organic light emitting device using the same | LT MATERIALS CO., LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-11812623-B2 | Hetero-cyclic compound and organic light emitting device using the same | LT MATERIALS CO., LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| WO-2023171951-A1 | ORGANIC LIGHT-EMITTING DEVICE, METHOD FOR MANUFACTURING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER | 엘티소재주식회사 | 2023-09-14 | — | — | WO | disclosed |
| US-20230036794-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2023-02-02 | — | — | US | disclosed |
| EP-4015515-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT Materials Co., Ltd. (KR) | 2022-06-22 | — | — | EP | disclosed |
| WO-2021034039-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 엘티소재주식회사 | 2021-02-25 | — | — | WO | disclosed |
| EP-3757095-A2 | HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LT Materials Co., Ltd. (KR) | 2020-12-30 | — | — | EP | disclosed |
| US-20200403157-A1 | HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LT MATERIALS CO., LTD. (KR) | 2020-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11812623-B2 | Hetero-cyclic compound and organic light emitting device using the same | CRY1, CRY2, PER2 | AHR 461/4885CYP2A6 422/4885ALOX5 1385/4885 |
| US-20230036794-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OCIAD1, OCIAD2, OXER1 | AHR 2001/4885CYP2A6 1216/4885ALOX5 320/4885 |
| US-20200403157-A1 | HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CRY1, CRY2, PER2 | AHR 461/4885CYP2A6 422/4885ALOX5 1385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.